The Cardiovascular Risks of Comorbid Insomnia and Sleep Apnea

A recent long-term study published in the Journal of the American Heart Association has identified a significant health threat for those suffering from both insomnia and obstructive sleep apnea, a condition known as COMISA. By tracking nearly one million U.S. veterans over two decades, researchers discovered that individuals living with both disorders face a cardiovascular disease risk more than three times higher than those without sleep issues. Furthermore, the study linked this dual diagnosis to a twofold increase in the risk of developing hypertension.

While insomnia and sleep apnea are often treated as separate issues, their combined effect creates a 'perfect storm' for the heart. During restorative sleep, the cardiovascular system naturally undergoes a period of recovery characterized by lower blood pressure and heart rate. However, sleep apnea disrupts this by causing intermittent oxygen deprivation, while insomnia keeps the body in a state of heightened physiological stress and inflammation. Together, these factors prevent the heart from achieving necessary rest, leading to long-term strain.

This research underscores the critical need to treat sleep health as a primary pillar of cardiovascular wellness, comparable to monitoring cholesterol or blood pressure. Many individuals remain unaware they have sleep apnea, often attributing their exhaustion to lifestyle factors despite practicing good sleep hygiene. The study suggests that if sleep remains fragmented or unrefreshing, patients should seek a professional sleep study to identify potential underlying apnea.

Fortunately, both conditions are highly treatable. Cognitive behavioral therapy for insomnia (CBT-I) and CPAP therapy for sleep apnea are effective interventions that can mitigate these risks. By addressing these sleep disorders early, patients can significantly reduce the burden on their cardiovascular system and improve their long-term health outcomes.